Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers

Aliment Pharmacol Ther. 1996 Oct;10(5):829-31. doi: 10.1046/j.1365-2036.1996.54196000.x.

Abstract

Aim: To compare the results of two short triple-therapy regimens, different only in the antisecretory drugs used, in patients with active duodenal ulcer and Helicobacter pylori infection.

Methods: All patients received a combination of clarithromycin 250 mg b.d. and tinidazole 500 mg b.d. for 1 week, in addition to an antisecretory drug: omeprazole 20 mg (50 patients) or ranitidine 300 mg (50 patients) twice daily for 1 week, followed by a single daily dose for a further 3 weeks. Upper gastrointestinal endoscopy, with rapid urease test and histological examination of antral and corpus biopsies, was performed prior to the treatment and at least 2 months after the discontinuation of the antisecretory therapy.

Results: Duodenal ulcer healing was documented in all patients at the endoscopic examination after therapy. H. pylori eradication was achieved in 46 of 50 patients (92%, 95% CI = 85-99%) in the omeprazole group and in 43 of 50 patients (86%, 95% CI = 76-96%) in the ranitidine group: the difference is not significant.

Conclusion: Omeprazole or ranitidine, in combination with clarithromycin and tinidazole, are equally effective in the eradication of H. pylori infection and healing of duodenal ulcers.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Ulcer Agents / administration & dosage
  • Anti-Ulcer Agents / pharmacology
  • Anti-Ulcer Agents / therapeutic use*
  • Antitrichomonal Agents / administration & dosage
  • Antitrichomonal Agents / pharmacology
  • Antitrichomonal Agents / therapeutic use
  • Chi-Square Distribution
  • Clarithromycin / administration & dosage
  • Clarithromycin / pharmacology
  • Clarithromycin / therapeutic use
  • Duodenal Ulcer / drug therapy*
  • Female
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects
  • Humans
  • Male
  • Middle Aged
  • Omeprazole / administration & dosage
  • Omeprazole / pharmacology
  • Omeprazole / therapeutic use*
  • Prospective Studies
  • Ranitidine / administration & dosage
  • Ranitidine / pharmacology
  • Ranitidine / therapeutic use*
  • Tinidazole / administration & dosage
  • Tinidazole / pharmacology
  • Tinidazole / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Antitrichomonal Agents
  • Tinidazole
  • Ranitidine
  • Clarithromycin
  • Omeprazole